NASDAQ:CLXT - Calyxt Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $13.57 -0.41 (-2.93 %) (As of 10/18/2018 06:00 AM ET)Previous Close$13.98Today's Range$13.45 - $14.124852-Week Range$12.65 - $27.98Volume70,292 shsAverage Volume80,900 shsMarket Capitalization$493.93 millionP/E Ratio-12.12Dividend YieldN/ABeta3.63 Company ProfileDiscussionAnalyst RatingsChartEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Calyxt, Inc., a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, improved oil composition canola, herbicide tolerant canola, improved quality alfalfa and herbicide tolerant alfalfa, late blight resistant potatoes, cold storable/reduced browning potatoes, improved protein composition soybeans, drought tolerant soybeans, herbicide tolerant soybeans, and improved yield soybeans. The Company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was founded in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A. Receive CLXT News and Ratings via Email Sign-up to receive the latest news and ratings for CLXT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Agricultural chemicals Sub-IndustryN/A SectorConsumer Staples SymbolNASDAQ:CLXT CUSIPN/A Webwww.calyxt.com Phone651-683-2807 Debt Debt-to-Equity Ratio0.16 Current Ratio21.27 Quick Ratio21.27 Price-To-Earnings Trailing P/E Ratio-12.12 Forward P/E Ratio-13.30 P/E GrowthN/A Sales & Book Value Annual Sales$510,000.00 Price / Sales860.76 Cash FlowN/A Price / CashN/A Book Value$2.08 per share Price / Book6.52 Profitability EPS (Most Recent Fiscal Year)($1.12) Net Income$-25,980,000.00 Net Margins-7,253.78% Return on Equity-45.34% Return on Assets-36.39% Miscellaneous Employees35 Outstanding Shares32,350,000Market Cap$493.93 million Calyxt (NASDAQ:CLXT) Frequently Asked Questions What is Calyxt's stock symbol? Calyxt trades on the NASDAQ under the ticker symbol "CLXT." How were Calyxt's earnings last quarter? Calyxt Inc (NASDAQ:CLXT) released its earnings results on Wednesday, August, 1st. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.22) by $0.04. The firm earned $0.20 million during the quarter, compared to analyst estimates of $0.10 million. Calyxt had a negative net margin of 7,253.78% and a negative return on equity of 45.34%. View Calyxt's Earnings History. When is Calyxt's next earnings date? Calyxt is scheduled to release their next quarterly earnings announcement on Monday, November 12th 2018. View Earnings Estimates for Calyxt. What price target have analysts set for CLXT? 5 brokers have issued 12 month price objectives for Calyxt's shares. Their predictions range from $18.00 to $34.25. On average, they anticipate Calyxt's stock price to reach $26.65 in the next year. This suggests a possible upside of 96.4% from the stock's current price. View Analyst Price Targets for Calyxt. What is the consensus analysts' recommendation for Calyxt? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Calyxt in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Calyxt. What are Wall Street analysts saying about Calyxt stock? Here are some recent quotes from research analysts about Calyxt stock: 1. According to Zacks Investment Research, "Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. It researches and develops seeds and food ingredients for agricultural, feed, and food applications as well as offers fat saturation and gluten reduction in soybean oil and wheat. Calyxt, Inc. is based in New Brighton, United States. " (10/11/2018) 2. Jefferies Financial Group Inc analysts commented, "CLXT announced in an 8-K filing that CFO Bryan Corkal has resigned from the company effective immediately. While the announcement was unexpected, we believe it was a personal decision & not the result of any disagreement with the company or a sign of any operational / financial issues. In fact, we are incrementally positive on near term fundamentals following meetings with mgmt earlier this week." (6/22/2018) Who are some of Calyxt's key competitors? Some companies that are related to Calyxt include Terra Nitrogen (TNH), American Vanguard (AVD), CVR Partners (UAN), Marrone Bio Innovations (MBII), Evogene (EVGN), Wynnstay Group (WYN), China Green Agriculture (CGA), Arcadia Biosciences (RKDA), Bion Environmental Technologies (BNET), Eden Research (EDEN), SenesTech (SNES), Kiwa Bio-Tech Products Group (KWBT), Cavitation Technologies (CVAT) and Syngenta (SYT). Who are Calyxt's key executives? Calyxt's management team includes the folowing people: Dr. Daniel Voytas Ph.D., Founder & Chief Science Officer (Age 55)Dr. Yves Joseph Ribeill, Interim CEO & Director (Age 58)Mr. Eric Dutang, Interim CFO & Principal Accounting Officer (Age 44)Ms. Jennifer Moore, VP of CommunicationsMr. Manoj Sahoo, Chief Commercial Officer (Age 43) When did Calyxt IPO? (CLXT) raised $101 million in an IPO on Thursday, July 20th 2017. The company issued 6,100,000 shares at a price of $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities acted as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers. Who are Calyxt's major shareholders? Calyxt's stock is owned by a number of of institutional and retail investors. Top institutional investors include Essex Investment Management Co. LLC (0.06%). Company insiders that own Calyxt stock include Alain Godard, Andre Choulika, Bryan WJ Corkal, Daniel F Voytas, Federico A Tripodi, Glenn R Bowers, Manoj Sahoo, Michel Arbadji, Philippe Dumont and SA Cellectis. View Institutional Ownership Trends for Calyxt. Which major investors are buying Calyxt stock? CLXT stock was acquired by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC. Company insiders that have bought Calyxt stock in the last two years include Philippe Dumont and SA Cellectis. View Insider Buying and Selling for Calyxt. How do I buy shares of Calyxt? Shares of CLXT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Calyxt's stock price today? One share of CLXT stock can currently be purchased for approximately $13.57. How big of a company is Calyxt? Calyxt has a market capitalization of $493.93 million and generates $510,000.00 in revenue each year. The company earns $-25,980,000.00 in net income (profit) each year or ($1.12) on an earnings per share basis. Calyxt employs 35 workers across the globe. What is Calyxt's official website? The official website for Calyxt is http://www.calyxt.com. How can I contact Calyxt? Calyxt's mailing address is 2800 MOUNT RIDGE ROAD, ROSEVILLE MN, 55113. The company can be reached via phone at 651-683-2807 or via email at [email protected] MarketBeat Community Rating for Calyxt (NASDAQ CLXT)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 139 (Vote Outperform)Underperform Votes: 133 (Vote Underperform)Total Votes: 272MarketBeat's community ratings are surveys of what our community members think about Calyxt and other stocks. Vote "Outperform" if you believe CLXT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLXT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 10/18/2018 by MarketBeat.com StaffFeatured Article: What is the Dividend Aristocrat Index?